Select Page

South Delhi Pharma, New Delhi, India

MULPLETA (lusutrombopag tablets) for oral use

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

MULPLETA is a prescription medicine. MULPLETA is used to treat low platelet count (thrombocytopenia) in adults with chronic liver disease.
INDICATIONS AND USAGE
MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
DOSAGE FORMS & STRENGTHS
Tablet: 3 mg
Manufactured By: Shionogi Inc.
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “MULPLETA (lusutrombopag tablets) for oral use” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures. It is being manufactured and marketed in Japan by Shionogi. It was approved by the U.S. Food and Drug Administration (FDA) in July 2018, and NICE in January 2020.

It was approved for medical use in the European Union in February 2019.

6 reviews for MULPLETA (lusutrombopag tablets) for oral use

  1. www.mytjx.com login

    It’s a pity you don’t have a donate button! I’d certainly donate to this outstanding blog! I guess for now i’ll settle for bookmarking and adding your RSS feed to my Google account. I look forward to new updates and will share this website with my Facebook group. Talk soon!

    http://cse.google.co.vi/url?q=https://www.clipsit.net/www-mytjx-com-associates-login-and-self-service/

  2. Activate nbcnews

    F*ckin awesome things here. I am very glad to see your post. Thanks a lot and i’m looking forward to contact you. Will you kindly drop me a e-mail?

    https://skodawiki.com/index.php?title=User:TracieReay899

  3. read this

    I’m still learning from you, while I’m improving myself. I absolutely enjoy reading all that is written on your site.Keep the information coming. I loved it!

    https://pinshape.com/items/28805-3d-printed-widowmakers-widows-kiss-collapsible-sniper-rifle-overwatch

  4. read this

    Hi there, just became alert to your blog through Google, and found that it’s really informative. I am gonna watch out for brussels. I will appreciate if you continue this in future. Numerous people will be benefited from your writing. Cheers!

    http://google.co.zw/url?q=https://theintouchnews.com/skywest-named-best-place-to-work/

  5. getinkpreferred com

    Right now it looks like BlogEngine is the preferred blogging platform out there right now. (from what I’ve read) Is that what you are using on your blog?

    https://74.125.68.191/url?q=https://blogfreely.net/copperspanish/chase-ink-company-card-choices-and-review

  6. Nordstromcard

    Wonderful blog! I found it while browsing on Yahoo News. Do you have any suggestions on how to get listed in Yahoo News? I’ve been trying for a while but I never seem to get there! Cheers

    https://marvelcomics.faith/wiki/Be_Wary_of_an_Easy_Authorization_Mastercard

Add a review

Your email address will not be published.